Actively Recruiting
Effects of the Consumption of Test Product on Urination in Healthy Japanese Adults
Led by Indena S.p.A · Updated on 2026-02-06
76
Participants Needed
2
Research Sites
27 weeks
Total Duration
On this page
Sponsors
I
Indena S.p.A
Lead Sponsor
O
Orthomedico Inc.
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to test in Japanese adults who experience concerns regarding urinary frequency. The main question it aims to answer is: •Does consumption of Cranberry Phospholipids reduce daytime urinary frequency? Participants will be given the following tasks: * Take two tablets daily containing Cranberry Phospholipid for eight weeks. * Answer the questionnaire on the overactive bladder (OAB)-specific quality of life (QOL). * Answer the questionnaire on OAB symptoms. * Answer the questionnaire on urinary frequency during the study period. Researchers will compare Cranberry Phospholipids and placebo groups to see if Cranberry Phospholipids reduces daytime urinary frequency.
CONDITIONS
Official Title
Effects of the Consumption of Test Product on Urination in Healthy Japanese Adults
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Japanese
- Men or women
- Adults
- Healthy individuals
- Individuals with positive urine leukocytes at baseline
- Individuals with urinary urgency score less than two or total overactive bladder symptom score less than three at baseline
- Individuals with relatively high "frequent urination during the daytime hours" symptom bother score at baseline
You will not qualify if you...
- Individuals undergoing medical treatment or with history of malignant tumor, heart failure, or myocardial infarction
- Individuals with pacemaker or implantable cardioverter defibrillator
- Individuals treated for cardiac arrhythmia, liver disease, kidney disease, cerebrovascular disorder, rheumatism, diabetes, dyslipidemia, hypertension, or other chronic diseases
- Individuals using "Foods for Specified Health Uses", "Foods with Functional Claims", or other functional foods/beverages daily
- Individuals regularly taking medications (including herbal medicines) and supplements
- Individuals allergic to medicines or test-product-related products
- Individuals with urinary pain
- Individuals undergoing or requiring treatment for urinary-related diseases such as benign prostatic hypertrophy, prostatitis, prostate cancer, overactive bladder, hypoactive bladder, cystitis, interstitial cystitis, bladder cancer, bladder stones, urethritis, urethral stricture, neurological disease, polyuria, nocturnal polyuria
- Individuals with overactive bladder symptoms (urinating eight or more times per day and urinary urgency at least once a week)
- Individuals waking two or more times to urinate at bedtime
- Pregnant, breastfeeding, or planning pregnancy
- Individuals enrolled in other clinical trials within 28 days before or during this trial
- Individuals judged ineligible by the physician
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Nerima Medical Association Minami-machi Clinic
Nerima-ku, Tokyo, Japan, 176-0002
Actively Recruiting
2
Medical Corporation Seishinkai, Takara Clinic
Shinagawa-Ku, Tokyo, Japan, 141-0022
Actively Recruiting
Research Team
N
Naoko Suzuki
CONTACT
A
Asami Baba, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here